Transition of blood glucose level in a patient with pregnancy-associated fulminant type 1 diabetes mellitus

J Diabetes Investig. 2021 May;12(5):894-896. doi: 10.1111/jdi.13419. Epub 2020 Oct 26.

Abstract

We report on the transition in blood glucose levels before and after the onset of fulminant type 1 diabetes mellitus in a perinatal woman. In week 38 of pregnancy, before which the patient had normal glucose tolerance, idiopathic acute pancreatitis was diagnosed. Five days thereafter, she became hypoglycemic, so we closely monitored her blood glucose levels. A total of 13 days later, she was hyperglycemic with a blood glucose level >16.0 mmol/L and glycated hemoglobin of 6.4%. Her fasting serum C-peptide reactivity level was 3.6 ng/mL on the 5th day, and 0.2 ng/mL on the 18th day. Multiple insulin injection therapy was administered since the 18th day; after that, ketoacidosis did not occur. The patient was diagnosed with fulminant type 1 diabetes mellitus based on hyperglycemia without high glycated hemoglobin levels and sudden onset insulin-dependent diabetes. Monitoring glucose levels in the case of idiopathic acute pancreatitis during pregnancy and prompt initiation of insulin therapy are important.

Keywords: Blood glucose; Fulminant type 1 diabetes mellitus; Pregnancy.

Publication types

  • Case Reports

MeSH terms

  • Acute Disease
  • Adult
  • Blood Glucose / analysis
  • C-Peptide / blood
  • Diabetes Mellitus, Type 1 / blood*
  • Diabetes Mellitus, Type 1 / drug therapy
  • Diabetes Mellitus, Type 1 / etiology
  • Diabetes, Gestational / blood*
  • Diabetes, Gestational / drug therapy
  • Diabetes, Gestational / etiology
  • Fasting / blood
  • Female
  • Glycated Hemoglobin / analysis
  • Humans
  • Hypoglycemia / blood*
  • Hypoglycemia / drug therapy
  • Hypoglycemia / etiology
  • Hypoglycemic Agents / therapeutic use
  • Insulin / therapeutic use
  • Pancreatitis / blood*
  • Pancreatitis / complications
  • Pregnancy
  • Pregnancy Complications / blood*
  • Pregnancy Complications / etiology

Substances

  • Blood Glucose
  • C-Peptide
  • Glycated Hemoglobin A
  • Hypoglycemic Agents
  • Insulin